aluates Reports

$ 0.0

Automative

Global Microarray-based Non-Invasive Prenatal Testing Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-19O18052

BUY CHAPTERS

Global Microarray-based Non-Invasive Prenatal Testing Market Research Report 2024

Code: QYRE-Auto-19O18052

Report

August 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina Inc

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

Microarray-based Non-Invasive Prenatal Testing Market

For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.

The global Microarray-based Non-Invasive Prenatal Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Microarray-based Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Microarray-based Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Microarray-based Non-Invasive Prenatal Testing in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Microarray-based Non-Invasive Prenatal Testing include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Microarray-based Non-Invasive Prenatal Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microarray-based Non-Invasive Prenatal Testing.

The Microarray-based Non-Invasive Prenatal Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microarray-based Non-Invasive Prenatal Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microarray-based Non-Invasive Prenatal Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microarray-based Non-Invasive Prenatal Testing Market Report

Report Metric	Details
Report Name	Microarray-based Non-Invasive Prenatal Testing Market
Segment by Type	Trisomy Detection Microdeletion Syndromes Other
Segment by Application	Hospitals & Clinics Independent Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, Sequenom
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microarray-based Non-Invasive Prenatal Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The main players in the Microarray-based Non-Invasive Prenatal Testing Market are Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, Sequenom

What are the Application segmentation covered in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The Applications covered in the Microarray-based Non-Invasive Prenatal Testing Market report are Hospitals & Clinics, Independent Laboratories

What are the Type segmentation covered in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The Types covered in the Microarray-based Non-Invasive Prenatal Testing Market report are Trisomy Detection, Microdeletion Syndromes, Other

Recommended Reports

Prenatal Genetic Testing

Non-Invasive Testing

Microarray & Genomics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Trisomy Detection

1.2.3 Microdeletion Syndromes

1.2.4 Other

1.3 Market by Application

1.3.1 Global Microarray-based Non-Invasive Prenatal Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals & Clinics

1.3.3 Independent Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Perspective (2019-2030)

2.2 Global Microarray-based Non-Invasive Prenatal Testing Growth Trends by Region

2.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Region (2019-2024)

2.2.3 Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (2025-2030)

2.3 Microarray-based Non-Invasive Prenatal Testing Market Dynamics

2.3.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends

2.3.2 Microarray-based Non-Invasive Prenatal Testing Market Drivers

2.3.3 Microarray-based Non-Invasive Prenatal Testing Market Challenges

2.3.4 Microarray-based Non-Invasive Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue

3.1.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue (2019-2024)

3.1.2 Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Players (2019-2024)

3.2 Global Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Microarray-based Non-Invasive Prenatal Testing Revenue

3.4 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio

3.4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microarray-based Non-Invasive Prenatal Testing Revenue in 2023

3.5 Global Key Players of Microarray-based Non-Invasive Prenatal Testing Head office and Area Served

3.6 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Product and Application

3.7 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Type

4.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Type (2019-2024)

4.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (2025-2030)

5 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Application

5.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Application (2019-2024)

5.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size (2019-2030)

6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

6.4 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2019-2030)

7.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

7.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size (2019-2030)

8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size (2019-2030)

9.2 Latin America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

9.4 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2019-2030)

10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Introduction

11.1.4 Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.1.5 Agilent Technologies Recent Development

11.2 Ariosa Diagnostics (Roche)

11.2.1 Ariosa Diagnostics (Roche) Company Details

11.2.2 Ariosa Diagnostics (Roche) Business Overview

11.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Introduction

11.2.4 Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.2.5 Ariosa Diagnostics (Roche) Recent Development

11.3 BGI Group

11.3.1 BGI Group Company Details

11.3.2 BGI Group Business Overview

11.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Introduction

11.3.4 BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.3.5 BGI Group Recent Development

11.4 Eurofins LifeCodexx GmbH

11.4.1 Eurofins LifeCodexx GmbH Company Details

11.4.2 Eurofins LifeCodexx GmbH Business Overview

11.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Introduction

11.4.4 Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.4.5 Eurofins LifeCodexx GmbH Recent Development

11.5 Illumina

11.5.1 Illumina Company Details

11.5.2 Illumina Business Overview

11.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Introduction

11.5.4 Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.5.5 Illumina Recent Development

11.6 Laboratory Corporation of America

11.6.1 Laboratory Corporation of America Company Details

11.6.2 Laboratory Corporation of America Business Overview

11.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Introduction

11.6.4 Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.6.5 Laboratory Corporation of America Recent Development

11.7 Myriad Genetics

11.7.1 Myriad Genetics Company Details

11.7.2 Myriad Genetics Business Overview

11.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Introduction

11.7.4 Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.7.5 Myriad Genetics Recent Development

11.8 Natera

11.8.1 Natera Company Details

11.8.2 Natera Business Overview

11.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Introduction

11.8.4 Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.8.5 Natera Recent Development

11.9 PerkinElmer Inc

11.9.1 PerkinElmer Inc Company Details

11.9.2 PerkinElmer Inc Business Overview

11.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Introduction

11.9.4 PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.9.5 PerkinElmer Inc Recent Development

11.10 Quest Diagnostics

11.10.1 Quest Diagnostics Company Details

11.10.2 Quest Diagnostics Business Overview

11.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Introduction

11.10.4 Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.10.5 Quest Diagnostics Recent Development

11.11 Sequenom

11.11.1 Sequenom Company Details

11.11.2 Sequenom Business Overview

11.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Introduction

11.11.4 Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

11.11.5 Sequenom Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina Inc

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

List of Tables

Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Trisomy Detection

Table 3. Key Players of Microdeletion Syndromes

Table 4. Key Players of Other

Table 5. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2019-2024)

Table 9. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2025-2030)

Table 11. Microarray-based Non-Invasive Prenatal Testing Market Trends

Table 12. Microarray-based Non-Invasive Prenatal Testing Market Drivers

Table 13. Microarray-based Non-Invasive Prenatal Testing Market Challenges

Table 14. Microarray-based Non-Invasive Prenatal Testing Market Restraints

Table 15. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players (2019-2024)

Table 17. Global Top Microarray-based Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microarray-based Non-Invasive Prenatal Testing as of 2023)

Table 18. Ranking of Global Top Microarray-based Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Headquarters and Area Served

Table 21. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Product and Application

Table 22. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2019-2024)

Table 26. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2025-2030)

Table 28. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2019-2024)

Table 30. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2025-2030)

Table 32. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2025-2030) & (US$ Million)

Table 47. Agilent Technologies Company Details

Table 48. Agilent Technologies Business Overview

Table 49. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product

Table 50. Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 51. Agilent Technologies Recent Development

Table 52. Ariosa Diagnostics (Roche) Company Details

Table 53. Ariosa Diagnostics (Roche) Business Overview

Table 54. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product

Table 55. Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 56. Ariosa Diagnostics (Roche) Recent Development

Table 57. BGI Group Company Details

Table 58. BGI Group Business Overview

Table 59. BGI Group Microarray-based Non-Invasive Prenatal Testing Product

Table 60. BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 61. BGI Group Recent Development

Table 62. Eurofins LifeCodexx GmbH Company Details

Table 63. Eurofins LifeCodexx GmbH Business Overview

Table 64. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product

Table 65. Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 66. Eurofins LifeCodexx GmbH Recent Development

Table 67. Illumina Company Details

Table 68. Illumina Business Overview

Table 69. Illumina Microarray-based Non-Invasive Prenatal Testing Product

Table 70. Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 71. Illumina Recent Development

Table 72. Laboratory Corporation of America Company Details

Table 73. Laboratory Corporation of America Business Overview

Table 74. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product

Table 75. Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 76. Laboratory Corporation of America Recent Development

Table 77. Myriad Genetics Company Details

Table 78. Myriad Genetics Business Overview

Table 79. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product

Table 80. Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 81. Myriad Genetics Recent Development

Table 82. Natera Company Details

Table 83. Natera Business Overview

Table 84. Natera Microarray-based Non-Invasive Prenatal Testing Product

Table 85. Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 86. Natera Recent Development

Table 87. PerkinElmer Inc Company Details

Table 88. PerkinElmer Inc Business Overview

Table 89. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product

Table 90. PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 91. PerkinElmer Inc Recent Development

Table 92. Quest Diagnostics Company Details

Table 93. Quest Diagnostics Business Overview

Table 94. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product

Table 95. Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 96. Quest Diagnostics Recent Development

Table 97. Sequenom Company Details

Table 98. Sequenom Business Overview

Table 99. Sequenom Microarray-based Non-Invasive Prenatal Testing Product

Table 100. Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024) & (US$ Million)

Table 101. Sequenom Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture

Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type: 2023 VS 2030

Figure 4. Trisomy Detection Features

Figure 5. Microdeletion Syndromes Features

Figure 6. Other Features

Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application: 2023 VS 2030

Figure 9. Hospitals & Clinics Case Studies

Figure 10. Independent Laboratories Case Studies

Figure 11. Microarray-based Non-Invasive Prenatal Testing Report Years Considered

Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Microarray-based Non-Invasive Prenatal Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players in 2023

Figure 16. Global Top Microarray-based Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microarray-based Non-Invasive Prenatal Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue in 2023

Figure 18. North America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 20. United States Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 24. Germany Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2019-2030)

Figure 32. China Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 40. Mexico Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2019-2030)

Figure 44. Turkey Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Agilent Technologies Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 48. Ariosa Diagnostics (Roche) Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 49. BGI Group Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 50. Eurofins LifeCodexx GmbH Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 51. Illumina Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 52. Laboratory Corporation of America Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 53. Myriad Genetics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 54. Natera Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 55. PerkinElmer Inc Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 56. Quest Diagnostics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 57. Sequenom Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Prenatal Testing Service Market Research Report 2025

Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Invasive Prenatal Testing NIPT Market Research Report 2024

Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030

Global Non invasive Parenteral Screening Market Insights Forecast to 2030

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Global Non invasive Preimplantation Genetic Testing Market Research Report 2024

Global Non invasive Parenteral Screening Instruments Market Insights Forecast to 2030

Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024

Global Non Invasive Prenatal Screening NIPS Market Research Report 2024

Global Prenatal Genetic Screening Test Market Research Report 2024

Global Non Invasive Cancer Detection Market Research Report 2024

Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024

Global SNP Microarray Testing and Analysis Market Research Report 2025

Global Prenatal DNA Sequencing Market Size Status and Forecast 2021 2027

Global Down Syndrome Genetic Testing Market Research Report 2024

Global High throughput Sequencing System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions